Idorsia, 2.125% 4aug2028, CHF (Conv.) (FIGI BBG011YS5HZ6, CH1128004079, WKN A3KUM8)
国内債券, 転換社債, Senior Unsecured
国内債券, 転換社債, Senior Unsecured
|
Idorsia is an independent biopharmaceutical company based on science and innovation. The company is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia was incorporated in March 2017 ...
Idorsia is an independent biopharmaceutical company based on science and innovation. The company is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia was incorporated in March 2017 and listed on the SIX Swiss Exchange.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡